Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.
about
A novel human T-leukemia virus type 1 cell-to-cell transmission assay permits definition of SU glycoprotein amino acids important for infectivityIdentification of a domain within the human T-cell leukemia virus type 2 envelope required for syncytium induction and replicationCurrent concepts regarding the HTLV-1 receptor complex.The humoral immune response to human T-cell lymphotropic virus type 1 envelope glycoprotein gp46 is directed primarily against conformational epitopes.Amino acid changes at positions 173 and 187 in the human T-cell leukemia virus type 1 surface glycoprotein induce specific neutralizing antibodies.Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13(II) is required for viral infectivity in vivo.An antiviral peptide targets a coiled-coil domain of the human T-cell leukemia virus envelope glycoprotein.Molecular aspects of HTLV-1 entry: functional domains of the HTLV-1 surface subunit (SU) and their relationships to the entry receptors.Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restrictionIsolation and characterization of a new simian T-cell leukemia virus type 1 from naturally infected celebes macaques (Macaca tonkeana): complete nucleotide sequence and phylogenetic relationship with the Australo-Melanesian human T-cell leukemia virIdentification and mapping of functional domains on human T-cell lymphotropic virus type 1 envelope proteins by using synthetic peptides.Conformation-specific antibodies targeting the trimer-of-hairpins motif of the human T-cell leukemia virus type 1 transmembrane glycoprotein recognize the viral envelope but fail to neutralize viral entryHuman T-cell lymphotropic virus type 1 (HTLV-1)-induced syncytium formation mediated by vascular cell adhesion molecule-1: evidence for involvement of cell adhesion molecules in HTLV-1 biology.Cellular Factors Involved in HTLV-1 Entry and PathogenicitIdentification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.High incidence of HAM/TSP-like symptoms in WKA rats after administration of human T-cell leukemia virus type 1-producing cells.Isolation of a human T-lymphotropic virus type I strain from Australian aboriginals.Complete nucleotide sequence of a highly divergent human T-cell leukemia (lymphotropic) virus type I (HTLV-I) variant from melanesia: genetic and phylogenetic relationship to HTLV-I strains from other geographical regions.Cottontail rabbit papillomavirus L1 protein-based vaccines: protection is achieved only with a full-length, nondenatured productMapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.Human T lymphotropic virus type 1 SU residue 195 plays a role in determining the preferential CD4+ T cell immortalization/transformation tropismHTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF165Analysis of functional conservation in the surface and transmembrane glycoprotein subunits of human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2.The synthetic peptide P-197 inhibits human T-cell leukemia virus type 1 envelope-mediated syncytium formation by a mechanism that is independent of Hsc70.Assessment of a new immunoassay for serological confirmation and discrimination of human T-cell lymphotropic virus infectionsTrypsin-sensitive and -resistant components in human T-cell membranes required for syncytium formation by human T-cell lymphotropic virus type 1-bearing cells.Neutralizing human monoclonal antibodies to conformational epitopes of human T-cell lymphotropic virus type 1 and 2 gp46.Identification of functional regions in the human T-cell leukemia virus type I SU glycoprotein.The mitogenic activity of human T-cell leukemia virus type I is T-cell associated and requires the CD2/LFA-3 activation pathway.In vitro peptide immunization of target tax protein human T-cell leukemia virus type 1-specific CD4+ helper T lymphocytes.Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry.
P2860
Q27480768-D637F2F6-7773-4586-B7DD-688C0258FDFFQ30453537-217DB9A6-C16E-4782-98DE-EEB9D18F8671Q33350169-AD99AF1C-BA31-4B4F-8FA2-089B1F6F433AQ33640882-10C4289E-DE12-4EBE-BCC7-79CD99E0C956Q33823227-DC73DE6C-7EF8-401A-9CE1-088CD3EA1A02Q34545731-B7131564-EE0E-41B7-BCC8-52BFE42E25F2Q34756124-50F10883-3166-4940-A6BC-290457F58884Q35261405-8D5E9D34-FE91-4ED6-97EA-0E0EEB66E006Q35847599-A74D6D8B-69A3-40D7-AB90-2667418684ACQ35850850-780EFC6A-378A-4D33-8E28-F8876E390A26Q35856454-63022201-98A1-41ED-AF11-D6B3F37C1905Q35857748-C680758C-7E9D-4BEB-80B9-2CD3E2D9562CQ35876633-677190C8-0419-434C-9E36-50263857C747Q36049779-A690A097-CA63-4A28-99A0-FCBBC395A23FQ36416769-5909A129-4190-49F4-B111-12D0CCBC66F9Q36635959-F56D5F10-4F16-4A01-A8EE-CC23D03A0C32Q36637030-EA55BFB4-EB87-4CBD-8D23-46F1026DEE14Q36641284-ED68E86B-01BF-43A3-BA44-BB50DDBB8A6DQ36641900-999301E0-1814-4132-96BC-78B7495424F0Q36650162-33FD5DA6-9AEA-444D-A288-8BF19320FC0DQ36651891-AB09A50C-8D04-4C34-92C0-0B473AFF5CCEQ37123327-B4B3ABDD-5697-4CAA-AA8B-BA4E10DB0576Q37201969-A5091938-D3AE-4FCA-8E43-552056A5C55CQ39580518-47AB13C0-28B3-4B33-A4A0-94DB1B3E6F21Q39604783-C018E87F-585A-4BE2-ABB7-8909A55FEAB8Q39630850-D848890C-6C2E-42A8-A706-BC403BFF19EBQ39877808-57A3A7FF-3023-4CA3-98BB-8AA2D6CDB1C0Q39880496-404C1693-1F83-4A44-BC52-6B31F4AD7031Q40040868-28675B13-0338-4256-AF1E-9E1E21F74AF2Q40045182-4025B245-5E9B-4038-8D8C-41CEC1A1E810Q40267146-9E50B91F-76BA-405A-8A02-C31461CE6A4FQ41494007-6DCA1233-3B24-46A9-8F13-586591FA1860
P2860
Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Mapping of homologous, amino-t ...... I gp46 envelope glycoproteins.
@ast
Mapping of homologous, amino-t ...... I gp46 envelope glycoproteins.
@en
type
label
Mapping of homologous, amino-t ...... I gp46 envelope glycoproteins.
@ast
Mapping of homologous, amino-t ...... I gp46 envelope glycoproteins.
@en
prefLabel
Mapping of homologous, amino-t ...... I gp46 envelope glycoproteins.
@ast
Mapping of homologous, amino-t ...... I gp46 envelope glycoproteins.
@en
P2093
P2860
P1433
P1476
Mapping of homologous, amino-t ...... I gp46 envelope glycoproteins.
@en
P2093
A McKnight
D E Spragion
M W McAdams
P R Clapham
R M Scearce
R R Randall
T J Palker
P2860
P304
P407
P577
1992-10-01T00:00:00Z